NIH-funded research NIH-funded research

Developing smart materials to heal infected chronic wounds

Official title: Multifunctional Intelligent Hierarchical Fibrous Biomaterials Integrated with Multimodal Biosensing and Feedback-Based Interventions for Healing Infected Chronic Wounds

Funded at University of Missouri-Columbia · NIH-10861531 · Data updated 2026-11-12

This study is working on new, smart bandages that help heal chronic wounds, especially for people with diabetes or older adults, by not only speeding up healing but also checking the wound and giving medicine when needed, so you can take care of your wound safely at home without going to the hospital as often.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startAugust 20, 2023
Project endAugust 19, 2025
Funding year2023
Award (this year)$776,719
NIH project number1R56EB034685-01
Project IDNIH-10861531 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic wounds, particularly those related to diabetes or other conditions that impair healing.

Less likely to help

Patients with acute wounds or those not experiencing chronic wound issues may not benefit from this research.

What this research studies

This research focuses on creating advanced fibrous biomaterials designed to treat chronic wounds, particularly those infected due to conditions like diabetes and aging. The approach involves developing materials that not only promote healing but also monitor the wound's condition in real-time and deliver medications as needed. By integrating biosensing technology, these materials aim to reduce the need for frequent hospital visits, allowing for safer home-based treatment options. The project addresses significant healthcare challenges by combining innovative materials science with telemedicine solutions.

Why it matters

Potential benefit: If successful, this research could significantly improve healing outcomes for patients with chronic wounds and reduce the risk of complications such as infections and amputations.

How similar studies have gone: Previous research has shown promise in using advanced biomaterials for wound healing, indicating that this approach could lead to meaningful advancements in treatment.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Yan, Zheng — University of Missouri-Columbia
  • Study coordinator: Yan, Zheng

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.